Chemed Corporation (CHE)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 617.95 |
| Open | 593.36 |
| Bid | 574.07 x 900 |
| Ask | 575.93 x 800 |
| Day's range | 561.00 - 593.36 |
| 52-week range | 492.84 - 654.62 |
| Volume | |
| Avg. volume | 80,369 |
| Market cap | 9.354B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 34.48 |
| EPS (TTM) | 16.63 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 1.60 (0.26%) |
| Ex-dividend date | 23 Feb 2024 |
| 1y target est | 690.00 |
ZacksChemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
Chemed's (CHE) first-quarter 2024 results reflect VITAS' impressive revenue growth and improved average revenues per patient per day.
ZacksChemed (CHE) Q1 Earnings Miss Estimates
Chemed (CHE) delivered earnings and revenue surprises of -4.94% and 0.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- GuruFocus.com
Chemed Corp (CHE) Q1 2024 Earnings: Mixed Results Amidst Segment Variances
Chemed Meets Revenue Projections But Sees Divergent Segment Performances
© 2024 Yahoo. All rights reserved.